ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Thoracic

May 28, 2014
J. Matthew Reinersman presents a new technique that combines POEM and laparoscopic dor fundoplication.
May 27, 2014
This metanalysis identified 26 eligible studies that assess the predictive value of PET for survival after induction therapy.  Complete metabolic response was associated with a 50% decrease in mortality and in tumor recurrence compared to no response.   
May 27, 2014
This retrospective single institution review assessed the incidence of hiatal hernia after minimally invasive esophagectomy (MIE).  Of 114 patients followed, 9 (8%) developed herniation, of whom 5 were symptomatic.  All were repaired laparoscopically, except 2 who underwent emergent surgery, with good results.
May 27, 2014
POEM is being increasingly used for primary treatment of achalasia.  This study evaluated POEM use for retreatment of 5 achalasia patients after prior laparoscopic esophageal myotomy and compared their results to 3 patients who underwent redo laparoscopic surgery.  Both groups had similar low complication rates and improved symptoms at intermediate-t
May 22, 2014
David Sugarbaker, Director of the International Mesothelioma Program, discusses the use of extrapleural pneumonectomy in the treatment of mesothelioma.
May 21, 2014
Pts undergoing salvage esophagectomy after definitive chemoradiotherapy were evaluated for perdictors of survival.  5-year survival was 30%, which was related to tumor recurrence rather than residual tumor, complete resection, N status, M status, and dissection of more than 15 nodes.  Additional neck dissection was not found to provide additional ben
May 21, 2014
This study evaluated over 200 RTCs of systemic therapy for NSCLC.  There has been a steady increase in the number of trials reporting outcomes for progression-free survival.  Over 50% of trials now report a positive outcome without meeting the primary endpoint of the trial.  Although the sample size of the trials is increasing, the magnitude of repor
May 20, 2014
From 2011-14, Thor Sundt, MD served as President of the CTSNet Board of Directors. In this interview, Dr. Sundt reflects on his time as CTSNet president, developments over the past several years, and the organization's future.
May 15, 2014
Betty Tong, Co-Director of the Lung Cancer Screening Program at Duke University Medical Center, discusses the process of establishing a lung cancer screening program.
May 13, 2014
This video shows a left thoracotomy approach to a giant epiphrenic diverticulum in a symptomatic patient.

Pages